XML 31 R14.htm IDEA: XBRL DOCUMENT
v3.26.1

Accrued expenses and other current liabilities | 12 Months Ended
--- | ---
Mar. 31, 2026
Accrued Liabilities and Other Liabilities [Abstract] |
Accrued expenses and other current liabilities | Accrued expenses and other current liabilities Accrued expenses and other current liabilities consisted of the following:
| March 31, 2026 |  | March 31, 2025
Accrued research and development costs | $ | 26,740 |  |  | $ | 19,606 |
Accrued compensation and benefits costs | 17,483 |  |  | 20,080 |
Accrued professional fees | 537 |  |  | 161 |
Other | 2,756 |  |  | 6,069 |
| $ | 47,516 |  |  | $ | 45,916 |

X
- Definition The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 720 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147483384/720-30-45-1 + Details
Name: | us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_AccruedLiabilitiesAndOtherLiabilitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration